Ublituximab Is Associated With Significant Improvement in the Multiple Sclerosis Functional Composite (MSFC): Results From the Phase 3 ULTIMATE I & II Studies

Drug Category: Array
Conference Category: Array
Lead Author: Steinman L, et al.
Published Date: 14/10/2021
Download Link: /wp-content/uploads/2021/10/Steinman-LB-ECTRIMS-2021-PH3-ULTIMATE-I-II.pdf
Download Text: Download
Popup Confirmation?:
site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
astra-migrate-meta-layouts: set
Scroll to Top